- Home
- ASYS vs VNRX Comparison
ASYS vs VNRX Comparison
Compare ASYS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- VNRX
- Stock Information
- Founded
- ASYS 1981
- VNRX N/A
- Country
- ASYS United States
- VNRX United States
- Employees
- ASYS N/A
- VNRX N/A
- Industry
- ASYS Industrial Machinery/Components
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ASYS Technology
- VNRX Health Care
- Exchange
- ASYS Nasdaq
- VNRX Nasdaq
- Market Cap
- ASYS 59.4M
- VNRX 52.4M
- IPO Year
- ASYS N/A
- VNRX N/A
- Fundamental
- Price
- ASYS $4.81
- VNRX $0.66
- Analyst Decision
- ASYS
- VNRX Strong Buy
- Analyst Count
- ASYS 0
- VNRX 5
- Target Price
- ASYS N/A
- VNRX $3.88
- AVG Volume (30 Days)
- ASYS 40.9K
- VNRX 318.9K
- Earning Date
- ASYS 08-06-2025
- VNRX 08-13-2025
- Dividend Yield
- ASYS N/A
- VNRX N/A
- EPS Growth
- ASYS N/A
- VNRX N/A
- EPS
- ASYS N/A
- VNRX N/A
- Revenue
- ASYS $90,826,000.00
- VNRX $1,308,361.00
- Revenue This Year
- ASYS N/A
- VNRX $563.72
- Revenue Next Year
- ASYS $28.60
- VNRX $160.43
- P/E Ratio
- ASYS N/A
- VNRX N/A
- Revenue Growth
- ASYS N/A
- VNRX 64.16
- 52 Week Low
- ASYS $3.20
- VNRX $0.40
- 52 Week High
- ASYS $6.96
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- ASYS 65.20
- VNRX 47.94
- Support Level
- ASYS $4.66
- VNRX $0.62
- Resistance Level
- ASYS $4.94
- VNRX $0.76
- Average True Range (ATR)
- ASYS 0.25
- VNRX 0.08
- MACD
- ASYS 0.04
- VNRX -0.02
- Stochastic Oscillator
- ASYS 86.14
- VNRX 12.47
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.